Article
Author(s):
Bret Lashner, MD, MPH, FACG, shares his thoughts about the first day of the 47th Annual Gastroenterology Update at the Cleveland Clinic, including the recent developments with inflammatory bowel disease and hepatitis C therapy.
Bret Lashner, MD, MPH, FACG, professor of gastroenterology and hepatology at the Cleveland Clinic and course director for the 47th annual gastroenterology update. Dr. Lashner shares his highlights of the meeting's first day, including the recent developments with inflammatory bowel disease and hepatitis C therapy.
Real-World Study Confirms Similar Efficacy of Guselkumab and IL-17i for PsA